Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-22

Clinical Trial Update: Eating Disorder Chatbot Optimization [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to optimize an eating disorder chatbot; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Eating Disorders | Phase 2 | Status: NOT_YET_RECRUITING